Twin Tree Management, LP Bluebird Bio, Inc. Put Options Transaction History

Twin Tree Management, LP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2019 Nov 12, 2019	SELL	$59.47 - $93.1 $3.88 Million - $6.08 Million	-65,300 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$75.84 - $105.21 $3.72 Million - $5.16 Million	49,000 Added 300.61%	65,300 $8.31 Million
Q1 2019 May 10, 2019	BUY	$64.44 - $104.11 $1.01 Million - $1.63 Million	15,700 Added 2616.67%	16,300 $2.56 Million
Q4 2018 Feb 13, 2019	SELL	$59.1 - $93.26 $561,450 - $885,970	-9,500 Reduced 94.06%	600 $60,000
Q3 2018 Nov 09, 2018	SELL	$88.86 - $117.49 $1.79 Million - $2.37 Million	-20,200 Reduced 66.67%	10,100 $1.48 Million
Q2 2018 Aug 08, 2018	SELL	$99.64 - $127.59 $707,444 - $905,889	-7,100 Reduced 18.98%	30,300 $4.76 Million
Q1 2018 May 09, 2018	SELL	$105.8 - $150.94 $3.29 Million - $4.69 Million	-31,100 Reduced 45.4%	37,400 $6.39 Million
Q4 2017 Feb 09, 2018	BUY	$81.25 - $130.7 $5.57 Million - $8.95 Million	68,500	68,500 $12.2 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.